Study Details

A Study to Assess the Analgesic Efficacy of ASP7962 in Patients with Pain Due to Osteoarthritis of the Knee

This trial is complete
The study has ended normally, and participants are no longer being examined or treated (that is, the last participant's last visit has occurred).

Clinicaltrials.gov ID

The unique identification code given to each clinical study upon registration at ClinicalTrials.gov.
NCT02611466

Astellas Study ID

The unique identification code given by the study sponsor.

7962-CL-0022

EudraCT ID

The unique identification code given to each clinical study upon registration at EudraCT (European Union Drug Regulating Authorities Clinical Trials Database).

2014-004996-22

Condition

Knee Joint Disease, Lower Back Pain

Phase

These clinical trials are done to learn if an experimental treatment helps participants who have a specific condition or disease. Phase 2 trials usually include a larger group of participants than Phase 1 trials.

Phase 2

Age

18 years - 80 years

Sex

Female & Male

Product

N/A

Type

A type of clinical study in which participants are assigned to groups that receive one or more intervention/treatment (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.

Interventional

Trial Dates

Feb 2016 - Sep 2017

Masking

Triple (Participant, Investigator, Outcomes Assessor)

Enrollment number

215

A Phase 2a, Randomized, Double-blind, Placebo- and Naproxen controlled, Parallel-group Study to Assess the Analgesic Efficacy of ASP7962 in Patients with Pain Due to Osteoarthritis of the Knee

Study summary

Study documents

Study Documents, including study results, are available after a study is completed or terminated, according to Astellas Transparency policy.

Get More Information

Would you like more information about clinical trial sites that are recruiting participants for A Study to Assess the Analgesic Efficacy of ASP7962 in Patients with Pain Due to Osteoarthritis of the Knee? Contact us by filling our your information to the right and we’ll respond to you.

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

Locations

Site ES34004

Santiago de Compostela, Spain, 15702

Site HU36006

Debrecen, Hungary, 4032

Site ES34002

A Coruna, Spain, 15006

Site DE49003

Leipzig, Germany, 4108

Site DE49007

Bayern, Germany, 80639

Site HU36003

Komarom, Hungary, 2900

Site HU36002

Baja, Hungary, 6500

Site ES34012

Barcelona, Spain, 8034

Site CZ42005

Praha 4, Czech Republic, 14059

Site HU36008

Balatonfured, Hungary, 8230

Site BE32005

Liege, Belgium, 4020

Site DE49006

Berlin, Germany, 10629

Site HU36004

Veszprem, Hungary, 8200

Site HU36001

Esztergom, Hungary, 2500

Site BE32003

Leuven, Belgium, 3000

Site BE32004

Yvoir, Belgium, 5530

Site HU36005

Bekescsaba, Hungary, 5600

Site ES34001

Barakaldo, Spain, 48903

Site CZ42003

Kunovice, Czech Republic, 686 04

Site GB44011

North Shields, United Kingdom, NE29 8NH

Site GB44006

London, United Kingdom, NW3 2QG

Site CZ42002

Praha 4, Czech Republic, 14000

Site GB44010

Oxfordshire, United Kingdom, OX3 7LD

Site ES34005

Madrid, Spain, 28046

Site BE32002

Merksem, Belgium, 2170

Site ES34008

Barcelona, Spain, 8028

Site ES34003

Bilbao, Spain, 48013

Site HU36009

Szeged, Hungary, 6722

Site GB44012

West Midlands, United Kingdom, WS11 5XY

Site GB44004

London, United Kingdom, SW17 0QT

Site ES34010

Valencia, Spain, 46015

Site CZ42006

Hradec Kralove, Czech Republic, 50341

Site DE49005

Munich, Germany, 80809

Site DE49004

Deggingen, Germany, 73326

Site DE49001

Magdeburg, Germany, 39120

Site GB44001

Cambridge, United Kingdom, CB2 2QQ

Site HU36007

Budapest, Hungary, 1027